Business

Latest News

eye on pharma banner
Eye on Pharma: Sandoz Files Antitrust Suit; Yuflyma Interchangeability; Costco’s Ustekinumab Pick

April 22nd 2025

Sandoz's antitrust suit against Amgen, the FDA’s interchangeability designation for Celltrion’s adalimumab biosimilar, and the inclusion of an ustekinumab biosimilar in Costco’s prescription program highlight growing momentum to expand biosimilar access and affordability for patients with chronic inflammatory diseases.

white house  | Image credit: Vacclav - stock.adobe.com
President Trump Signs Executive Order to Bring Down Drug Prices

April 16th 2025

biosimilar business deal | Image credit: Mongkolchon - stock.adobe.com
Latest Biosimilar Deals Signal Growth Across Immunology, Oncology Markets

April 14th 2025

FDA Approved. | Image Credit: gguy - stock.adobe.com .jpeg
FDA Approves Biocon Biologics' Bevacizumab Biosimilar

April 10th 2025

paroxysmal nocturnal hemoglobinuria | Image credit: olegganko - stock.adobe.com
Teva and Samsung Bioepis Launch Biosimilar Epysqli

April 9th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.